Erratum

This article refers to:

Costs of multiple sclerosis – extrapolation of Czech data to Polish patients

Correction to: Costs of multiple sclerosis – extrapolation of Czech data to Polish patients

Szmurło D, Fundament T, Ziobro M, et al. Costs of multiple sclerosis – extrapolation of Czech data to Polish patients. Expert Rev Pharmacoecon Outcomes Res 2014;14(3):451-8.

Following publication of this article, an error has been identified in Table 1. The unit for Betaferon is given incorrectly. It should be “Betaferon 250 MCG (interferon β-1b)” instead of “Betaferon 25 MG (interferon β-1b)”. The corrected Table 1 is given below.

Table 1. Unit costs.

Cost category	Unit costs (€)	Source	Cost category	Unit costs (€)	Source
Medication – disease-modifying drugs			Home care
Avonex (IFN-β-1a)	737	1	Home care (daily rate)	6	8
Rebif 22 MCG (IFN-β-1a)	921	1	Investigations and tests
Rebif 22 MCG+8,8 MCG (IFN-β-1a)	997	1	MRI scan	151	6
Rebif 44 MCG/0,5 ML (IFN-β-1a)	1067	1	Full-body CT scan	120	6
Betaferon 250 MCG (IFN-β-1b)	798	1	Head CT scan	51	6
Extavia 250 MCG/ML (IFN-β-1b)	747	1	Colonoscopy examination	64	6
Copaxone 20 MG/ML (glatiramer acetate)	705	1	Gastroscopy examination	26	6
Inpatient stay			Rehabilitation
Neurology inpatient stay (per stay)	888	2	Inpatient stay	46	7
ICU inpatient stay (per day)	758	2	Outpatient stay	5	7
Urology inpatient stay (per stay)	505	2	Medical equipment and devices
General surgery inpatient stay (per stay)	770	2	Wheelchair, manual	180	10
Orthopedics inpatient stay (per stay)	655	2	Wheelchair, electric	2435	10
Internal inpatient stay (per stay)	486	2	Positioning bed (per unit)	433	10
Outpatient stay			Hydraulic lift (per unit)	793	10
Neurologist – introductory/follow-up session (annual lump sum)	15	3	Stick (per unit)	4	9
Neurologist – specialist nurse (annual lump sum)	6	4	Walker (per unit)	59	9
General practitioner/internist (annual lump sum)	23	4	Crutches (per pair)	5	9
Urologist (per visit)	8	3	Anti-decubitus mattress (per unit)	134	9
Ophthalmologist (per visit)	7	3	Bath and shower seat (per unit)	49	10
Physiotherapist (per visit)	27	5	Incontinence product (per unit)	22	9
Orthopedist (per visit)	8	3	Medications – the other MS therapies
Psychiatrist/psychologist (per visit)	16	5	Methylprednisolonum	9	1
Specialist outpatient visit	9-32	3	Immunoglobulinum Humanum normale	266	1
			Azathioprinum	10	1
			Methotrexatum	6	1
			Mycophenolas mofetil	65	1
€1 = 4.1 PLN			Methylprednisolonum	9	1

1. Minister of Health’s regulation dated 28 August 2012 – reimbursement list [7].

2. Directive no. 11/2012/DSOZ of the President of NHF.

3. Directive no. 81/2011/DSOZ of the President of NHF.

4. Directive no. 85/2011/DSOZ of the President of NHF.

5. Directive no. 36/2012/DSOZ of the President of NHF.

6. Directive no. 96/2011/DSOZ of the President of NHF.

7. Directive no. 53/2010/DSOZ of the President of NHF.

8. Directive no. 20/2012/DSOZ of the President of NHF.

9. Minister of Health’s regulation dated 29.08.2009 [15].

10. Market price.